The pathophysiological roles of the angiotensin II type 2 receptor (AT 2 ) in cardiac hypertrophy remain unclear. By the targeted deletion of mouse AT 2 we were able to prevent the left ventricular hypertrophy resulting from pressure overload, while cardiac contractile functions remained normal. This implies that AT 2 is a mediator of cardiac hypertrophy in response to increased blood pressure. The effects of AT 2 deletion were independent of activation of embryonic genes for cardiac hypertrophy. However, p70 S6k , one of the key factors in cardiac hypertrophy, was markedly and specifically reduced in the ventricles of Agtr2 -/Y mice. We propose that p70 S6k plays a major role in AT 2 -mediated ventricular hypertrophy.
Introduction
Cardiac hypertrophy is an adaptive response of the heart to several forms of cardiac disease. Although sustained hypertrophy is an initial compensatory mechanism to preserve cardiac function, it is also a major risk factor for congestive heart failure and sudden death.
Angiotensin II (Ang II) plays an important role in the development of cardiac hypertrophy (1) . It is supplied by the circulating renin-angiotensinogen system and also is generated locally (2) . Treatment with angiotensin-converting enzyme inhibitors or Ang II-receptor antagonists induces marked but incomplete regression and prevention of the cardiac hypertrophy (3).
Of two major subtypes of Ang II receptors, type 1 (AT 1 ) and type 2 (AT 2 ), only the latter appears to increase under pathological conditions including cardiac hypertrophy (4) . However, its function remains controversial. Recent studies reported that pressure overload-induced left ventricular hypertrophy (LVH) still occurs in mice lacking the AT 1A gene (Agtr1A -/-) (5, 6) . In vitro studies on AT 2 in cultured cells have been difficult because its functions are often poorly reproducible. In the present in vivo studies, AT 2 gene-targeted mice (Agtr2 -/Y) were used to delineate the role of AT 2 in cardiac hypertrophy. The well-established ability of Ang II to induce cardiac hypertrophy prompted us to investigate the hypothesis that pressure overload-induced LVH would be prevented in the Agtr2 -/Y mice. ed as littermates by the same mating procedure. Experimental protocols were approved by Vanderbilt Animal Care Committee.
Pressure overload by aortic constriction. Pressure overload was produced by a modification of the published banding method of the abdominal aorta (8) . As controls, sham-operated mice were produced in both the Agtr2 -/Y and wild-type groups, using a procedure that was identical except for the aortic banding above the left renal artery.
Blood pressure measurement. To ascertain the pressure gradient of aortic constriction, the left carotid and femoral arteries were cannulated with stretched PE 10 intramedic polyethylene tubing (Clay Adams, division of Becton Dickinson and Co., Parsippany, New Jersey, USA) after characterization of cardiac properties. Blood pressure was measured under anesthesia with ketamine (50 mg/kg) and xylazine (20 mg/kg).
Echocardiography. Transthoracic echocardiography was performed with a Sonos 5500 with an S12 transducer (12 MHz) (Hewlett-Packard, Andover, Massachusetts, USA). Mice were weighed, anesthetized with ketamine (50 mg/kg) and xylazine (20 mg/kg), and settled in the left decubitus or supine position (9) . Good two-dimensional views of the left ventricle were obtained for guided M-mode measurements of the intraventricular septum (IVS), left ventricular end-diastolic diameter (LVDd), left ventricular posterior wall (LVPW), and left ventricular end-systolic diameter (LVDs (11) . Rabbit polyclonal phosphospecific antibodies to p70 S6k , extracellular signal-regulated kinase (ERK), p38 mitogen-activated protein kinase (p38 MAPK), and Jun NH 2 -terminal kinase (JNK) (New England Biolabs Inc., Beverly, Massachusetts, USA) and rabbit polyclonal antibodies to p70 S6k (New England Biolabs Inc.), collagen type I (Calbiochem-Novabiochem Corp., La Jolla, California, USA), and calcineurin (Santa Cruz Biotechnology Inc., Beverly, Massachusetts, USA) were used. ECL (Amersham Pharmacia Biotech, Piscataway, New Jersey, USA) was used for detection of immunoreactive bands. The outer borders of the bands were traced and the areas and densities were determined with the NIH image system.
Northern blot analysis. Northern blot analysis of Nkx 2.5, GATA4, myocyte enhancer factor 2C (MEF2C), β-myosin heavy chain (β-MHC), atrial natriuretic peptide (ANP), and GAPDH were performed as previously reported (12) .
RNase protection assay and calcineurin activity. Mouse AT 1 RNase protection assay was performed on aorticbanded Agtr2 -/Y and wild-type mice as previously reported (13) . The following primers for PCR were used: sense 5′-GGTGGGAATATTTG-GAAACAG-3′ and antisense 5′-AAGAA-GAAAAGCACAATCGCC-3′.
Calcineurin enzyme activity was determined as previously reported (14) .
Statistical analysis. For all statistical tests, multiple comparisons were performed by two-way ANOVA and Fisher's exact probability test. A P value less than 0.05 was considered significant.
Results
Effect of the pressure overload on systolic pressure. Changes in the left carotid artery systolic pressure after aortic constriction were determined by the direct method. Ten weeks after abdominal aortic constriction, left carotid artery systolic pressure increased significantly as compared with sham-operated mice. The magnitude of increase was similar in aortic-banded Agtr2 -/Y (56 ± 6 mmHg) and wild-type mice (62 ± 7 mmHg) ( Figure 1a) .
Determination of effects of the pressure overload on left ventricular dimension and function by echocardiography. In the native state, IVSs and LVPWs of the Agtr2 -/Y mice were thinner than those of the wild-type mice. Surprisingly, in the Agtr2 -/Y mice aortic constriction with concomitant elevation in systolic blood pressure induced little or no thickening of the ventricular walls, whereas marked LVH was seen in aortic-banded wild-type mice (Figure 1b) . LVM in the Agtr2 -/Y mice remained at almost the same levels as in sham-operated animals, whereas in the wild-type, a marked
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The (Figure 3, a and b) . AT 1 expression examined by RNase protection assay was also comparable between the Agtr2 -/Y and wild-type mice, and it remained comparable between the two groups 10 weeks after aortic constriction (data not shown). Thus, the features of the hearts of the Agtr2 -/Y mice are (a) normal ventricular function, (b) thinner ventricular wall thickness, and, most interestingly, (c) a markedly suppressed hypertrophic response to pressure overload.
Reduced collagen type I in Agtr2 -/Y mice. Left ventricular and interstitial collagen type I was markedly reduced in aortic-banded Agtr2 -/Y mice compared with aortic-banded wild-type mice (Figure 2, c and d) .
Markedly reduced p70 S6k in Agtr2 -/Y mice. To determine the signaling mechanisms underlying the resistance of the left ventricle of the Agtr2 -/Y mouse to growth stimulation by pressure overload, we compared the expression of various compounds involved in ventricular growth stimulation between the Agtr2 -/Y and wild-type mice. p70 S6k is one of the key factors in cardiac hypertrophy (15) . We found that phosphorylated p70 S6k and total p70 S6k were markedly reduced in the Agtr2 -/Y mice compared with the wild-type mice. Although aortic constriction increased both, their levels were still markedly below those of similarly treated wild-type mice (Figure 4a ). These observations suggest that the markedly attenuated hypertrophic response of the Agtr2 -/Y mouse may be due, in large part, to suppression of p70 S6k expression and activation in mice lacking the AT 2 receptor.
On the other hand, no difference was observed between the Agtr2 -/Y and wild-type mice in the following substances, which are considered to stimulate hypertrophy: phosphorylated ERK, p38 MAPK, JNK, calcineurin and calcineurin enzyme activity. Aortic banding did increase these factors slightly but to similar extents in the Agtr2 -/Y and wild-type mice (data not shown). No difference was detected in mRNA of the following well-known markers of ventricular hypertrophy: Nkx 2.5, GATA4, MEF2C, β-MHC, and ANP. In the native state, there was no significant difference between the groups in any of these markers. Two days after surgery, they were increased equally in both groups and reduced to base lines at 2 weeks after surgery ( ure 4b). Based on these results, we submit that attenuation of the signal pathway linking AT 2 to p70 S6k activation may be involved in the resistance to pressure overload-induced LVH in Agtr2 -/Y mice.
Discussion
The present studies demonstrate that pressure overload failed to induce LVH in the Agtr2 -/Y mice, whereas substantial LVH occurred in similarly treated wild-type mice. We also found that p70 S6k was markedly and specifically reduced whereas other hypertrophystimulating genes were not reduced. The AT 2 receptor appears to play a pivotal role in regulating pressure overload-induced LVH. Although many LVH-inducing genes and proteins have been described, by gain-of-function studies (16) (17) (18) , only a few have been shown to be responsible for cardiac hypertrophy by loss-of-function studies (19) . Particularly, we are not aware of any previous reports on the prevention of pressure overload-induced cardiac hypertrophy by deletion of the AT 2 receptor. The present results indicate a role for the expressed AT 2 receptor in the development of LVH in response to pressure overload. Several recent reports show that the AT 2 receptor functions counteract those of the AT 1 receptor (20) . In the present studies, we utilized the Agtr2 -/Y mice to delineate the mechanism of hypertrophy suppression associated with the chronic effect of the absence of the AT 2 receptor. In their native states, the Agtr2 -/Y mice had thinner ventricular walls than those of the wild-type, as shown in Figure 1 , b and c. However, their cardiac function was normal. After chronic aortic constriction, the cardiac function remained normal and cardiac enlargement was not seen in the Agtr2 -/Y mice. This indicates that the Agtr2 -/Y mice are not a model of dilated cardiomyopathy.
The ability to maintain normal cardiac function under pressure overload without evoking LVH is remarkable and seems to imply a primary pathological role of the LVH itself, rather than a secondary effect to compensate the pressure overload (21) . It is surprising that the left ventricular myocardium was able to maintain normal fiber length and contractility with no evidence of left ventricular dilation and failure. The markedly reduced collagen type I in aortic-banded Agtr2 -/Y mice may explain at least partly the normal contractile function (22, 23) .
Since cardiac hypertrophy is dependent mainly on protein synthesis, and the S6 kinases, particularly p70 S6k , play a pivotal regulatory role, the present observations suggest that the marked
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The Journal of Clinical Investigation | Volume 105 (25) . However, no difference was seen in the phosphorylated forms of any of the three MAPKs between the Agtr2 -/Y and wild-type mice. Since expression of ANP in aorticbanded Agtr2 -/Y mice, a sensitive marker for ventricular response to pressure overload (26) , is not different from that of aortic-banded wild-type mice, transcriptional mechanisms related to ANP gene expression may not be involved in the AT 2 -related hypertrophy. Recently, mechanisms involving calcineurin and nuclear factor of activated T cells-3 (NFAT-3), and/or activation of MEF2C by Ca 2+ -calmodulin-activated protein kinases II and IV, have been proposed for cardiac hypertrophy (27) . Again, these factors do not appear to be involved in the resistance to LVH in Agtr2 -/Y mice. In the Agtr2 -/Y mice, all of the hypertrophy-inducing factors discussed above were comparable to those of the wild-type mice.
The almost complete abrogation of hypertrophic response in the Agtr2 -/Y mouse heart may indicate that the presence of AT 2 is a major factor in the cardiac hypertrophy. This hypothesis finds support in the observation of Harada et al. (5) and Hamawaki et al. (6) that aortic constriction can still induce LVH in Agtr1A -/-mice and that AT 1 is only partially responsible for LVH. This latter conclusion is in contradiction to the current consensus that AT 1 and AT 2 have effects in antagonistic to growth regulation. However, the present in vivo studies suggest that AT 2 and p70 S6k can be determinants in regulating LVH, and they support the paradoxical phenotypic observation that AT 2 is essential for LVH rather than for its inhibition in the heart. However, it is not clear how these mechanisms are related to several reported AT 2 functions (28, 29) .
In summary, we have found that in Agtr2 -/Y mice, the left ventricle maintains normal contractile function but hypertrophic response to pressure overload is completely lost. The expression of ventricle-specific genes and marked suppression of p70 S6k , which regulates the DNA synthesis in Agtr2 -/Y mice, may provide an explanation for their loss of LVH response. Since a wide variety of other growth-regulating components are expressed normally, the present results indicate specific roles of p70 S6k regulation in the Agtr2 -/Y mouse heart and suggest that it is a major factor in mechanisms of cardiac hypertrophy.
